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IT iS commonly believed that the genesis of tumours is closely related.to the
mitoticactivity in theparent tissue (Willis, 1948 ; Mottram, 1944a, 1944b ; Beren-
blum and Shubik, 1947a, 1947b) and that agents such as croton oil whichheighten
mitotic activity facilitate the development of tumours. Green and Ghadiakv
(1951), Green and Savigear (1951) and BuRough (1952) have show-n that both
systemic and local cortisone have adepressant effect on the mitotic activity in the
the mouse epiderm'ls. Hence it seemed worth while to try the effect of cortisone
on the rate ofepidermal tumour production by chemical carcinogens since a sub-
stance which diminishes mitotic activity should delay or inhibit the production
of tumours.
METHODS.
Male mice, approximately 6-8 weeks old, of the WLL strain were used for an
experiments. They were housed in wooden cageIs 12 in. x 7 in x 6 in., six to a
cage, andgiven a diet ofrat cakes, cooked flakedmaize, dog-biscuits, cod-liveroil,
MArmite and-water, ad libitum. The hair in theinterscapularregion was removed
by clipping with electric clippers.
Experiment I.
Thirty mice were prepared as described above and divided into 2 equal groups
and treated as follows :
Group A (experimental : average weight at beginning of experiment 21-2 g.,
at end 24-3 g.) were painted twice a week with 2 drops of an 0-2 per cent solution
of 9:10 dimethyl-1:2 benzanthracene (D.M.BA) in 2 per cent paraffin in acetone,
and daily (except Saturdays and Sundays) with 2 drops of a cortisone suspension
containing- 12-5 mg./ml. over the same cutaneous area. Paintings with cortisone
were commenced 7 days before treatment with carcinogen was started. Both
treatments were continued until the termination oftheexperiment.
Group B (control: average weight at beginning of experiment 21 g., at end
26-2g.) received exactly the same treatment as Group A except that the cortisone
suspending fluid was substituted for the cortisone.
Experiment IL
Forty-five mice were divided into 3 equal groups and treated as follows:
Group A (experimental: -average weight at beginning of experiment 24-8 g.,
at end 26-59.) were painted twice a week with 2 drops of a solution ofDMBA (0-3292 F. W. GHADIALLY AND H. N. GREEN
per cent) in benzene, and daily (except Saturdays and Sundays) with 2 drops of a
cortisonesuspensioncontaining 12-5mg./ml. cortisone. Cortisone treatment com-
menced one day before treatment with carcinogen. Both treatments were con-
tinued till the termination of the experinient.
Group B (control: average weight at beginning of experiment 21 g., at end
26-2 g.) receivedexactly the same treatment as Group A except that the cortisone
suspending agent was used instead of cortisone.
Group C (control: average weight at beginning of experiment 21 g. at end
30-5g.) receivedcarcinogenpaintings identical withGroups A andB, but nopaint-
ing with cortisone or suspending fluid
Experiment III.
Sixty-three mice were divided into 3 groups and treated as follows
Group A (experimental: average weight at beginning ofexperiment 21-25 g.
at end 30 g.) were painted daily (except Saturda and Sundays) with 2 drops of
the cortisone suspension for afortnight. At this pointthey received a single appli-
cation of 2 drops of I per cent DMBA in benzene, after which no treatment was
given for a fortnight. At the end of this rest period 2 drops of 5 per cent croton
oil in acetone was painted in the same area twice a week for aperiod of 15 weeks.
Group B (control: average weight at beginning ofexperiment 21-5 g., at end
30 g.) received the same treatment as Group A at identical time intervals but
cortisone suspending agent was used instead of cortisone.
Group C (control : average weight at beginning of experiment 21 g., at end
30-5 g.) received no treatment with either cortisone orsuspending agent, the treat-
ment otherwise being similar to that ofGroups A and B.
Experiment IV.
Asingleapplication of2drops of I per cent DMBA in benzene was made to each
of 43 mice. No treatment ofany sort wasgiven for the nextfortnight, at the end
of which period the animals were divided into 3 groups which were treated as
follows :
Group A (experimental: average weight at beginning of experiment 28 g., at
end 31-6 g.) were painted daily (except Saturdays and Sundays) with 2 drops of
the cortisone suspension and twice a week with 2 drops of 5 per cent croton oil
in acetone in the same area. Both treatments were continued till the termination
of the experiment.
Group B (control: average weight at beginning ofexperiment 27-4 g., at end
33-1 g.) received the same treatment as Group A except that cortisone suspending
agent was used instead of cortisone.
Group C (control: average weight at beginning of experiment 28 g., at end
37g.) received no treatment with either cortisone orsuspendingagent but received
croton oil treatment as in Groups A and B.
Tables I to IV showthe rates at which tumoursdeveloped inthe various groups.
Tables I and 11 clearly show the pronounced inhibition ofpapilloma formation in
mice receiving cortisone treatment. Thus in Experiment I no papillomata were
seen compared with 15 tumours in the control group at the end of the 12th week.
In Experiment II only one papilloma was observed in the cortisone-treated group
while 88 and 42 tumours respectively were seen in the 2 control groups at the end
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RESUTiTS.
TABLEI.-Showing Rate of Tumour Development in Corti8one Treated and Control
Anima18 during Treatment with 9:10 Dimethyl-1:2 Benzanthracene (Experi-
ment I). 1- . -1 1. 1- . - I Number of mice
surviving.
t -A.
Suspending
./ortisone. fluid.
Number ofmice
showing tumours.
r
Suspending
ortisone. fluid.
0 0
0 2
0 5
0 5
0 3
0 8
0 7
0 6
Total number
of tumours.
.1,4- -N
Suspending
Cortisone. fluid.
0 0
0 2
0 6
0 6
0 4
0 15
0 8
0 15
Time
(weeks).
5
6
I
8
9
10
H
12
13
13
13
13
13
13
12
12
Cc
13
13
13
13
13
12
7
7
TABLEII.-Showing Rate of Tumour Development in Cortisone Treated and Control
Animals during Treatment with 9:10-Dimethyl-1:2 Benzanthracene (Experi-
ment II).
1- . Number ofmice
surviving.
-A
r
Corti- Suspend-
sone. ingfluid. Nil.
13 14 14
13 14 14
13 14 14
13 14 13
9 14 13
6 14 12
2 11 11
2 11 9
2 11 9
Number of mice
showing tumours.
-A- r I
Corti- Suspend-
sone. ing fluid. Nil.
0 0 0
0 3 2
0 6 6
0 8 6
0 9 7
1 12 8
1 10 8
1 11 8
1 11 8
Total number
of tumours.
-A..
r I
Corti- Suspend-
sone. ing fluid. Nil.
0 0 0
0 3 4
0 8 11
0 15 11
0 26 (1) 20
1 44 (1) 25 (2)
1 52 33 (2)
1 80 39 (1)
1 88 (1) 42 (1)
Time
(weeks).
5
6
7
8
9
10
11
12
13
Figures in brackets show number ofmalignant growths.
TABLE III.-Showing RateofTumourDevelopment t'n Cortisone Treated and Control
Animals after a Single Treatment with 9:1O-Dimethyl-1:2 Benzanthracenefol-
lowed by Croton Oil.
Cortisone apphed during the
" pre-induction
" and
" induction
" phase
but not during the
" development
" phase ofcareinogenesis. Time calcu-
lated from commencement of croton oil treatment.
Niimber of mice
surviving.
Tixne r A
I
in Corti- Suspend-
weeks. sone. ing fluid. Nil.
Number of mice
showing tumours.
Ir
Corti- Suspend-
sone. ing fluid. Nil.
0 0 0
3 3 3
7 7 8
7 5 9
6 6 11
7 7 12
6 9 13
7 9 11
9 10 10
9 9 10
9 12 9
7 9 8
Total number
of tumours.
Corti- Suspend-
sone. ing fluid. Nil.
0 0 0
6 3 3
11 11 10
10 6 11
19 9 14
19 15 is
18 14 24
19 16 16
23 15 19
24 14 19
21 14 18
15 9 17
---I-I)
- --- 1
18
18
18
18
18
18
18
18
18
18
18
18
21
21
21
21
21
21
21
21
21
21
20
19
5
6
7
8
9
10
I 1
12
13
14
15
16
14
13
13
13
13
13
13
13
13
13
12
12
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TABLEIV.---Showing RateofTumourDevelopment in Cortisone Treated and Control
Ani-nmls after a Single Treatment with 9:10-Dimethyl-1:2 Benzanthracen-cfol-
lowed by Croton Oil.
Cortisone treatment apphed during
" developmental
"phase of careino-
genesis. Time calculated from commencement of croton oil treatment.
Number of mice Number of mice Total number
surviving. showing tumours. of tumours.
Time
in Corti- Suspend- Corti- Suspend- Corti- Suspend-
weeks. sone. ing fluid. Nil. sone. ing fluid Nil. sone. ing fluid. Nil.
7 15 13 13 0 0 0 0 0 0
8 15 13 13 0 1 2 0 1 2
9 15 13 13 2 5 7 2 9 11
10 15 13 13 1 5 6 1 10 10
11 15 13 13 1 7 9 1 18 28
12 15 12 13 2 6 10 3 18 37
13 15 12 13 0 7 10 0 14 33
14 15 12 13 0 8 10 0 14 32
Experiment III was performed to test the effect of local cortisone during the
period just prior to, and coincident with (i.e., the
" pre-induction
" and
" induc-
tion
" periods) asingleapphcation ofcarcinogen. Table III shows that under these
circumstances cortisone has failed to inhibit tumourformation, a result instriking
contrast with Experiments I and IL
Experiment IV was performed to test the effect of local cortisone during the
developmental
" phase ofcarcinogenesis and the results (Table IV) clearly show
that in this phase cortisone inhibits papilloma formation and the very few which
formed quickly regressed.
DISCUSSION.
Results ofExperiments I-and 11stronglysuggest that cortisone appliedlocally
suppressespapilloma formationby apowerful carcinogen. This effect isprobably
producedbythe knownepidermal mitotic depressant action of cortisone. Further,
as cortisone fails to produce this effect when it is applied in the
" pre-induction
"
and
" induction
" phase ofcarcinogenesis, nosupport isgiven to Mottram'shypo-
thesis, that the inducing action of a carcinogen is exerted on a dividing cell. The
number of cells in mitosis in the cortisone pre-treated animals during the period
of
" induction
" would be few or none and on this hypothesis far less papillomata
should have appeared whereas the numbersequalled that ofthe controls.
Baserga and Shubik (1954) have obtained essentially siniilar results. They
observed that the induction of skin tumours in Swiss micebymethylcholanthrene
was markedly inhibited by the adniinistration of 0-5 mg. of cortisone daily,'While
Rusch (1953) found that papillomata formation by benzpyrene was much dimi-
nished by local application or feeding with cortisone. No attempt was made to
determine at what stage of carcinogenesis cortiso'ne exerts its inhibitory action,
but the experiments were continued for alongerperiod than ours and carcinomata
eventually appeared at the same time as in the controls. If confirmed, our con-
ceptions of the proliferative
" developmental
" phase of carcinogenesis might
have to be modified, for at present it is difficult to see how an agent can so effec-
tively suppress papilloma production and yet have no effect on the appearance ofCORTISONE AND CHEMICAL CARCINOGENESIS 295
carcinomata. The findings of Green and Savigear (1951) may bear on this point.
They showed that after 4 applications of DMB, over 14 days, the epidermal cells
ofthe mouse ear became relatively refractory to the antimitotic action ofcortisone
given systematically. This was confirmed by an in vitro technique (Green, 1952).
It might be expected therefore that chemical carcinogenesis would not be delayed
or prevented by cortisone, whereas in fact the present results show that it was. A
possible explanation of this apparent discrepancy is that the time of appearance
of resistance to cortisone depends directly on the rate of mitosis. If this rate is
strongly diminished (by cortisone) from the outset of carcinogen treatment resist-
ance would then appear much more slowly. At the time ofits appearing however
the treated area of epidermis would be rich in cells in the "induction" phase of
carcinogenesis since cortisone does not affect this process. Such a mass of cells,
after a long exposure to the carcinogen, could be envisaged, when finally they had
become completely resistant to cortisone, as emerging as a frank carcinoma. On
this basis the longer the delay in starting cortisone treatment the more ineffective
would its suppression of papillomata development be. Experiments to decide
this point are being made.
SUMMARY.
Local treatment with cortisone, from the commencement of 9:10-dimethyl-l1:2
benzanthracene painting inhibitedpapillomata formation in the mouse skin almost
completely. Cortisone also produced this effect when allowed to act during the
"developmental" phase of carcinogenesis but was quite ineffective when applied
solely during the "pre-induction" and "induction" phases.
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